Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Stroke Cerebrovasc Dis. 2020 Jun;29(6):104814. doi: 10.1016/j.jstrokecerebrovasdis.2020.104814. Epub 2020 Apr 21.
Spasticity is one of the main complications in poststroke survivors leading to difficulties in walking and standing resulting in high levels of disability.
The aim of the study was to investigate the effects of deep dry needling on lower limb dysfunction in poststroke spastic patients.
A randomized clinical trial conducted in poststroke survivors who were assigned to one of 2 groups: Deep dry needling (intervention group) and sham dry needling (control group). The primary outcome measures were Modified Modified Ashworth Scale (MMAS) and functional tests (timed up and go test, 10-meter walk test). Secondary outcome measures were active ankle dorsiflexion range of motion (AROM), passive ankle dorsiflexion range of motion (PROM), single leg stance test, and Barthel index. All measurements were assessed at baseline (T0), immediately after the third session 1 week later (T1), and 1 month after the end of the intervention (T2).
We recruited 24 patients (71% male; mean age 57 ± 10 years; 26.4 ± 1.8 kg•m; time since event: 25.2 ± 12.5 months). There were significant improvements in MMAS, timed up and go test, 10-meter walk test, Barthel scale, and PROM (P < .05) in the intervention group compared to controls across the time-points. There were no significant improvements in AROM assessments (P > .05).
Deep dry needling decreases muscle spasticity and improves lower limb function and gait speed in poststroke survivors.
痉挛是脑卒中幸存者的主要并发症之一，导致行走和站立困难，从而导致高度残疾。
本研究旨在探讨深刺干针疗法对脑卒中后痉挛患者下肢功能障碍的影响。
一项随机临床试验纳入了脑卒中幸存者，将其分为深刺干针组（干预组）和假干针组（对照组）。主要结局指标为改良改良 Ashworth 量表（MMAS）和功能测试（计时起立行走测试、10 米步行测试）。次要结局指标为主动踝关节背屈活动度（AROM）、被动踝关节背屈活动度（PROM）、单腿站立测试和巴氏指数。所有测量均在基线（T0）、第三次治疗后 1 周（T1）和干预结束后 1 个月（T2）进行评估。
我们共招募了 24 名患者（71%为男性；平均年龄 57 ± 10 岁；26.4 ± 1.8 kg•m；发病时间：25.2 ± 12.5 个月）。与对照组相比，干预组在 MMAS、计时起立行走测试、10 米步行测试、巴氏指数和 PROM 方面的评分均有显著改善（P <.05）。AROM 评估无显著改善（P >.05）。
深刺干针疗法可降低脑卒中后患者的肌肉痉挛程度，改善下肢功能和步行速度。
